Shire sues Colony for filing to market ADHD generic

04/9/2007 | American City Business Journals

Shire, maker of Adderall, and an Icelandic company that wants to market a generic version are in a U.S. court in Baltimore over a patent-infringement lawsuit brought by Shire. The Shire suit says Colony Pharmaceuticals, an affiliate of Actavis, applied to the FDA to market a generic of Shire's popular attention deficit hyperactivity disorder drug, which still has patent protection. Shire settled cases with other firms out of court.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC